14-day Premium Trial Subscription Try For FreeGet Free
Currently predicting for Mon, 11 Dec 2023

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.49 8.12 %
R2 2.42 5.38 %
R1 2.38 3.68 %
Current price: 2.30
Support S1 2.26 -1.80 %
S2 2.22 -3.49 %
S3 2.16 -6.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.59 12.61 %
R2 2.47 7.39 %
R1 2.40 4.35 %
Current price 2.30
Support S1 2.06 -10.43%
S2 2.02 -12.17%
S3 1.90 -17.39%

AGRX Predictions History

2 years ago
Rybkarybka predicted that AGRX for 2021-11-01 is going $0.81 (-0.86%)

2 years ago
JS predicted that AGRX for 2021-10-28 is going $0.767 (-3.51%)

2 years ago
JS predicted that AGRX for 2021-10-28 is going

2 years ago
Rybkarybka predicted that AGRX for 2021-10-28 is going $0.83 (6.15%)

2 years ago
Rybkarybka predicted that AGRX for 2021-10-15 is going $0.81 (6.58%)

2 years ago
JS predicted that AGRX for 2021-10-12 is going $0.783 (1.77%)

2 years ago
Rybkarybka predicted that AGRX for 2021-10-12 is going $0.740 (-3.82%)

2 years ago
Rybkarybka predicted that AGRX for 2021-10-11 is going $0.740 (9.69%)

2 years ago
Mian Abu Bakr Shuja predicted that AGRX for 2021-04-28 is going $2.10 (14.13%)

Rank:

2 years ago
JS predicted that AGRX for 2021-01-14 is going $2.82 (-0.70%)

Click to get the best stock tips daily for free!

About Agile Therapeutics

Agile Therapeutics Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to h... AGRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT